Background illustration for clinical trials search

Paid Clinical Trials Lakeland

Discover 1,839 paid clinical trials in Lakeland, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

QTX3034 in Patients With KRAS G12D Mutation

for
Solid Tumors
Location: Tampa FL, Sarasota FL, Durham NC, Nashville TN,
Sponsor: Quanta Therapeutics

Sex: All

Age: 18+

Code: NCT06227377

Phase1, Recruiting

A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery

for
Peritoneal Carcinomatosis, Ovarian Cancer
Location: Tampa FL
Sponsor: Oncoinvent Solutions AS

Sex: Female

Age: 18+

Code: NCT06504147

Phase2, Recruiting

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung
Location: Tampa FL, St. Petersburg FL, Ocala FL, Fort Myers FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06890598

Phase3, Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Tampa FL, Orlando FL, Altamonte Springs FL, Sarasota FL,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase1, Recruiting

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Tampa FL, Atlanta GA, Chattanooga TN, Baton Rouge LA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05379985

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry

for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Location: Tampa FL, Miami FL, Ottawa, Calgary, Seattle WA
Sponsor: Immune Oncology Research Institute

Sex: All

Age: 0+

Code: NCT05430971

Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Tampa FL, Jacksonville FL, Fairhope AL, Daphne AL,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 0+

Code: NCT06031688

Phase2, Recruiting

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

for
Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
Location: Tampa FL, Orlando FL, Miami FL, Atlanta GA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 18+

Code: NCT06765109

Phase3, Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

for
Solid Tumor
Location: Tampa FL, Augusta GA, New York NY, Chicago IL,
Sponsor: Eisai Inc.

Sex: All

Age: 18+

Code: NCT04300556

Phase1, Phase2, Recruiting

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

for
Solid Tumors
Location: Tampa FL, Jacksonville FL, Spartanburg SC, Durham NC,
Sponsor: ORIC Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05315700

Phase1, Phase2, Recruiting

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

for
Adult Acute Myeloid Leukemia
Location: Tampa FL, Atlanta GA, Cincinnati OH, Cleveland OH,
Sponsor: Priothera SAS

Sex: All

Age: 18 - 70+

Code: NCT05429632

Phase3, Recruiting

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Tampa FL, Gainesville FL, Savannah GA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06616584

Phase2, Phase3, Recruiting

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

for
Prostate Cancer (Adenocarcinoma),
Location: Tampa FL, Myrtle Beach SC, Baltimore MD, Boston MA,
Sponsor: Acerand Therapeutics (Hong Kong) Limited

Sex: Male

Age: 18+

Code: NCT06801236

Phase1, Recruiting

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In

for
NSCLC Stage IV
Location: Tampa FL, Fort Lauderdale FL, Charleston SC, Atlanta GA,
Sponsor: ImmunityBio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06745908

Phase3, Recruiting

Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia

for
Severe Aplastic Anemia
Location: Tampa FL, Atlanta GA, Birmingham AL, Charlotte NC,
Sponsor: Medical College of Wisconsin

Sex: All

Age: 3 - 70+

Code: NCT06517641

Phase2, Recruiting

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Tampa FL, Pembroke Pines FL, Hollywood FL, Savannah GA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05642572

Phase2, Recruiting

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

for
Endometrial Cancer
Location: Tampa FL, Orlando FL, Augusta GA, Louisville KY,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: Female

Age: 18 - 70

Code: NCT06481592

Phase2, Recruiting

Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer

for
Ovarian Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: Female

Age: 18+

Code: NCT05316129

Phase1, Recruiting

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

for
Ovarian Cancer, Cholangiocarcinoma Recurrent,
Location: Tampa FL, Houston TX, Philadelphia PA, Madison WI
Sponsor: Verismo Therapeutics

Sex: All

Age: 18+

Code: NCT05568680

Phase1, Recruiting

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

for
Chronic Myelomonocytic Leukemia,
Location: Tampa FL, Houston TX, Boston MA, Rochester MN,
Sponsor: Solu Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06950034

Phase1, Recruiting